Please upgrade your browser.
Collecting duct carcinoma (CDC) of the kidney, also known as Bellini’s tumor, is a rare type of renal cancer, accounting for some 1% of all renal malignancies.
Selectively targeting established tumor vasculature with tumor vascular-disrupting agents (VDAs) represents a promising and innovative approach to improving the efficacy of standard anticancer therapies.
Caregivers and family members play an important and prominent role throughout the kidney cancer treatment process. The Kidney Cancer Association is pleased to offer Lotsa Helping Hands as part of our commitment to supporting caregivers of those battling kidney cancer.
Transitional cell cancer is a cancer occurring in the urinary system, i.e., the kidneys, urinary bladder and accessory organs of the urinary system and occurs in the inner tissue lining of these hollow organs.
Health information technology (health IT) makes it possible for health care providers to better manage patient care through secure use and sharing of health information.
Get a maximum tax deduction and join the fight against kidney cancer by donating your old vehicle to the Kidney Cancer Association.
Rintatolimod was first synthesized in the 1970s and has been proposed as a treatment for illnesses such as CFS, HIV, hepatitis B, hepatitis C, and cancers, including renal cell cancer...
Meeting agenda and related materials, including abstract previews
Will this happen to patients living with kidney cancer under ObamaCare? Roy Dashwood, 81, who has advanced kidney cancer, will have to pay for all his treatments, test and travel, out of pocket, if he takes a new drug recommended by his oncologist.
Curis, Inc. (CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Patent and Trademark Office has issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90 (HSP90) inhibitor, which is being developed by Curis' licensee Debiopharm.
|Powered by NeonCRM|